EU GMP Annex 11 & 21 CFR Part 11 – Computerised Systems & E-Records

User Access and Security Controls for Annex 11/Part 11–Regulated Systems User Access and Security Controls for Annex 11/Part 11–Regulated Systems Ensuring that computerized systems used in pharmaceutical operations comply with regulations such as EU GMP Annex 11 and 21 CFR Part 11 is paramount for maintaining data integrity and security. Regulatory bodies, including the US FDA, EMA, and MHRA, have…

Audit Trail Design and Review Under Annex 11 and Part 11 Audit Trail Design and Review Under Annex 11 and Part 11 The design and review of audit trails in the pharmaceutical industry are critical to regulatory compliance and data integrity. Under the EU GMP Annex 11 and the 21 CFR Part 11 of the US FDA regulations, the design,…

Data Integrity by Design: Applying Annex 11, Part 11 and GAMP 5 Principles Data Integrity by Design: Applying Annex 11, Part 11 and GAMP 5 Principles In the field of pharmaceuticals, the importance of data integrity cannot be overstated. Regulatory authorities like the US FDA, EMA, and MHRA have emphasized the need for robust systems that ensure data integrity by…

Electronic Signatures: Meeting Part 11 and Annex 11 Requirements The integration of electronic signatures within pharmaceutical environments is governed by stringent regulatory frameworks that aim to ensure the authenticity, integrity, and accountability of electronic records. In this article, we will explore the expectations set forth by the US FDA under 21 CFR Part 11, the EU GMP Annex 11, and…

Spreadsheet and Small Tool Validation for Annex 11/Part 11 Compliance Spreadsheet and Small Tool Validation for Annex 11/Part 11 Compliance The pharmaceutical industry is characterized by strict regulatory requirements that ensure the quality and integrity of data generated through computerized systems. This article provides a detailed, step-by-step guide on validating spreadsheets and small tools to ensure compliance with EU GMP…

Validating Cloud and SaaS GxP Systems Under Annex 11 and Part 11 As the pharmaceutical industry increasingly adopts digital technologies, understanding the regulatory framework for validating cloud-hosted Good Practice (GxP) systems becomes imperative for compliance. This article elucidates the regulatory expectations set forth by the US FDA, EMA, and other governing bodies concerning the validation of cloud environments and Software…

Supplier Assessment and Hosting Agreements for GxP Cloud Environments Supplier Assessment and Hosting Agreements for GxP Cloud Environments In recent years, the pharmaceutical industry has increasingly adopted cloud-based solutions to enhance operational efficiency and flexibility. However, with these advancements come a myriad of regulatory requirements that must be adhered to, especially when dealing with Good Practice (GxP) cloud hosting environments….

Periodic Review of GxP Computerised Systems: Annex 11 and Part 11 Expectations Introduction to GxP Computerised Systems Validation The validation of GxP (Good Practice) computerized systems is a critical component of pharmaceutical quality assurance. It ensures that systems used in the manufacture, control, and distribution of pharmaceutical products comply with relevant regulatory requirements, including EU GMP Annex 11 and 21…

Computer System Validation Documentation: Annex 11 and Part 11–Ready Packages In the highly regulated pharmaceutical industry, the implementation and maintenance of computerized systems must comply with stringent guidelines set forth by regulatory authorities like the US FDA, EMA, and MHRA. Computer System Validation (CSV) ensures that these systems perform as intended, thereby guaranteeing data integrity, patient safety, and product quality….

Common Annex 11/Part 11 Data Integrity Findings in FDA, EMA and MHRA Inspections Common Annex 11/Part 11 Data Integrity Findings in FDA, EMA and MHRA Inspections As pharmaceutical companies operate within the stringent guidelines set forth by regulatory agencies, understanding common data integrity findings related to Annex 11 and 21 CFR Part 11 is imperative. This article provides a comprehensive…